151 related articles for article (PubMed ID: 26047368)
1. Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinoma.
Marks EI; Brennan M; El-Deiry WS
Cancer Biol Ther; 2015; 16(8):1136-9. PubMed ID: 26047368
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of a transient increase in carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with metastatic colorectal cancer receiving chemotherapy].
Li YH; An X; Xiang XJ; Wang ZQ; Wang FH; Feng F; Jiang WQ; He YJ; Xu RH
Ai Zheng; 2009 Sep; 28(9):939-44. PubMed ID: 19728911
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors related to lymph node metastases after neoadjuvant therapy for locally advanced rectal cancer].
Zeng ZF; Ding PR; Pan ZZ; Lin JZ; Li LR; Lu ZH; Wu XJ; Kong LH; Zhou ZG; Wan DS
Ai Zheng; 2009 Sep; 28(9):923-7. PubMed ID: 19728908
[TBL] [Abstract][Full Text] [Related]
4. Predictors of sensitivity to preoperative chemoradiotherapy of rectal adenocarcinoma.
Yan H; Wang R; Zhu K; Zhao W; Jiang S; Feng R; Xu X; Meng X; Sun H; Zhang H; Mu D; Xu Z
Tumori; 2011; 97(6):717-23. PubMed ID: 22322837
[TBL] [Abstract][Full Text] [Related]
5. [Multivariate analysis of clinicopathologic factors correlated with pathological complete response following preoperative radiotherapy in rectal adenocarcinoma].
Lin JZ; Pan ZZ; Zeng ZF; Ding PR; Wan DS
Ai Zheng; 2009 Sep; 28(9):919-22. PubMed ID: 19728907
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Pretreatment Serum CA199 in Patients with Locally Advanced Rectal Cancer Treated with CRT Followed by TME with Normal Pretreatment Carcinoembryonic Antigen Levels.
Huang D; Lin Q; Song J; Xu B
Dig Surg; 2021; 38(1):24-29. PubMed ID: 33171467
[TBL] [Abstract][Full Text] [Related]
7. Locally advanced rectal adenocarcinoma: Treatment sequences, intensification, and rectal organ preservation.
Bigness A; Imanirad I; Sahin IH; Xie H; Frakes J; Hoffe S; Laskowitz D; Felder S
CA Cancer J Clin; 2021 May; 71(3):198-208. PubMed ID: 33592118
[No Abstract] [Full Text] [Related]
8. Neoadjuvant conformal chemoradiation with induction chemotherapy for rectal adenocarcinoma. A prospective observational study.
Fekete Z; Muntean AS; Hica Ş; Rancea A; Resiga L; Csutak C; Todor N; Nagy VM
J Gastrointestin Liver Dis; 2014 Jun; 23(2):171-8. PubMed ID: 24949609
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of carcinoembryonic antigen for monitoring tumor progression during palliative chemotherapy in metastatic colorectal cancer.
Kim G; Jung EJ; Ryu CG; Hwang DY
Yonsei Med J; 2013 Jan; 54(1):116-22. PubMed ID: 23225807
[TBL] [Abstract][Full Text] [Related]
11. A carcinoembryonic antigen-secreting adenocarcinoma arising in tailgut cyst: clinical implications of carcinoembryonic antigen.
Cho BC; Kim NK; Lim BJ; Kang SO; Sohn JH; Roh JK; Choi ST; Kim SA; Park SE
Yonsei Med J; 2005 Aug; 46(4):555-61. PubMed ID: 16127782
[TBL] [Abstract][Full Text] [Related]
12. A long-term survival case of rectal cancer with multiple pulmonary metastases treated with multidisciplinary chemotherapy.
Ando H; Shitara Y; Mogami Y; Kobayashi T; Yajima T; Tani M; Morinaga N; Ishizaki M; Hashimoto S; Nakabayashi T; Kuwano H
Int Surg; 2013; 98(4):311-4. PubMed ID: 24229015
[No Abstract] [Full Text] [Related]
13. Relations of Changes in Serum Carcinoembryonic Antigen Levels before and after Neoadjuvant Chemoradiotherapy and after Surgery to Histologic Response and Outcomes in Patients with Locally Advanced Rectal Cancer.
Saito G; Sadahiro S; Ogimi T; Miyakita H; Okada K; Tanaka A; Suzuki T
Oncology; 2018; 94(3):167-175. PubMed ID: 29268274
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the value of carcinoembryonic antigen reduction ratio as a prognosis factor in rectal cancer.
Huang CS; Lin JK; Wang LW; Liang WY; Lin CC; Lan YT; Wang HS; Yang SH; Jiang JK; Chen WS; Lin TC; Chang SC
Am J Surg; 2014 Jul; 208(1):99-105. PubMed ID: 24524862
[TBL] [Abstract][Full Text] [Related]
15. Elevated Pretreatment CEA and CA19-9 Levels are Related to Early Treatment Failure in Esophageal Adenocarcinoma.
van der Kaaij RT; Voncken FEM; van Dieren JM; Snaebjornsson P; Korse CM; Grootscholten C; Aleman BMP; van Sandick JW
Am J Clin Oncol; 2019 Apr; 42(4):345-350. PubMed ID: 30724779
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: role of CEA and CA 19-9.
Weissenberger C; Von Plehn G; Otto F; Barke A; Momm F; Geissler M
Anticancer Res; 2005; 25(3A):1787-93. PubMed ID: 16033101
[TBL] [Abstract][Full Text] [Related]
17. CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma.
Pectasides D; Mylonakis A; Kostopoulou M; Papadopoulou M; Triantafillis D; Varthalitis J; Dimitriades M; Athanassiou A
Am J Clin Oncol; 1997 Aug; 20(4):348-53. PubMed ID: 9256887
[TBL] [Abstract][Full Text] [Related]
18. [A case of increased resectability with preoperative chemotherapy FOLFOX4 for unresectable rectal cancer].
Mouri T; Hada T; Kato K; Hirabayashi T; Masubuchi M
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1765-8. PubMed ID: 18931585
[TBL] [Abstract][Full Text] [Related]
19. Serum elevation of CEA and CA 19-9 in an aggressive variant of prostatic carcinoma.
Brandes A; Weinmann M; Reichmann U; Becker G; Gärtner HV; Bamberg M
Acta Oncol; 2001; 40(7):879-81. PubMed ID: 11859991
[No Abstract] [Full Text] [Related]
20. Survival Outcomes After Surgical Management of the Primary Tumor With and Without Radiotherapy for Metastatic Rectal Adenocarcinoma: A National Cancer Database (NCDB) Analysis.
Renz P; Wegner RE; Hasan S; Brookover R; Finley G; Monga D; Raj M; McCormick J; Kirichenko A
Clin Colorectal Cancer; 2019 Jun; 18(2):e237-e243. PubMed ID: 30905549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
